Clinical Trial Update: Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study [Phase 2]

View source ↗

Summary

A Phase 2 prospective study evaluating modified FOLFOXIRI plus a targeted therapy as first-line treatment for advanced colorectal cancer (colon cancer stage IV)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Targeted therapy

Snippet

Sponsor: Al-Azhar University | Conditions: Neoplasm Malignant, Colon Cancer Stage 4 | Phase 2 | Status: RECRUITING